Authors: KLEIN SI MOLINO BF CZEKAJ M GARDNER CJ CHU V BROWN K SABATINO RD BOSTWICK JS KASIEWSKI C BENTLEY R WINDISCH V PERRONE M DUNWIDDIE CT LEADLEY RJ

Citation: Si. Klein et al., DESIGN OF A NEW CLASS OF ORALLY-ACTIVE FIBRINOGEN RECEPTOR ANTAGONISTS, Journal of medicinal chemistry, 41(14), 1998, pp. 2492-2502

Authors: BOSTWICK JS KASIEWSKI CJ CHU V KLEIN SI SABATINO RD PERRONE MH DUNWIDDIE CT COOK JJ LEADLEY RJ

Citation: Js. Bostwick et al., ANTITHROMBOTIC ACTIVITY OF RG13965, A NOVEL PLATELET FIBRINOGEN RECEPTOR ANTAGONIST, Thrombosis research, 82(6), 1996, pp. 495-507

Authors: GORDON EM DALISA R TANG H SALAZAR R SABATINO RD DORIO R KOHN DB HOLT J

Citation: Em. Gordon et al., CHARACTERIZATION OF A MONOCLONAL ANTIBODY-PURIFIED RECOMBINANT FACTOR-IX PRODUCED IN HUMAN HEPATOMA (HEPG2) CELL-CULTURES AFTER RETROVIRAL VECTOR-MEDIATED TRANSFER, International journal of pediatric hematology/oncology, 2(3), 1995, pp. 185-191

Authors: CHU V SABATINO RD KLEIN SI BIECHY KD LEADLEY RJ BOSTWICK JS KASIEWSKI CJ PERRONE MH DUNWIDDIE CT

Citation: V. Chu et al., IN-VITRO CHARACTERIZATION OF A NOVEL FIBRINOGEN RECEPTOR ANTAGONIST -RPR-110173, Blood, 86(10), 1995, pp. 352-352